Neogen brings new test to detect carcinogen in dairy products

Reveal Q+ for Aflatoxin M1 can detect as little as 150 parts per trillion of the toxins in milk samples in just minutes

US based Neogen Corporation has recently announced that it has launched a quicker, easier test to detect aflatoxin M1, a known cancer-causing toxin of concern to the global dairy industry.

Neogen’s new Reveal Q+ for Aflatoxin M1 can detect as little as 150 parts per trillion (ppt) of the toxins in milk samples in just minutes. The new test is designed for use with Neogen’s Raptor Integrated Analysis Platform, which controls the timing, temperature, and reading of the test strips — allowing testers to simply add samples and walk away.

Aflatoxin M1 is a carcinogenic metabolite of aflatoxin B1 that is produced in the rumen of dairy cattle. The new test can detect aflatoxin M1 in milk within a range of 150 to 600 ppt. 

Reveal Q+ for Aflatoxin M1 utilizes the same incubation temperature and time as Neogen’s BetaStar antibiotic tests, including tests for beta-lactams (e.g., amoxicillin, ampicillin, and penicillin) and tetracyclines. The Raptor platform automatically incubates and analyzes up to three milk samples independently and simultaneously. The system also protects the integrity and consistency of testing data by processing and analyzing results without additional operator input.

Neogen Corporation develops and markets products dedicated to food and animal safety. The company’s Food Safety Division markets dehydrated culture media and diagnostic test kits to detect foodborne bacteria, natural toxins, food allergens, drug residues, plant diseases, and sanitation concerns.